Alessandra Sottini

ORCID: 0000-0001-5404-228X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and B-cell Immunology
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 and healthcare impacts
  • Immunotherapy and Immune Responses
  • Multiple Sclerosis Research Studies
  • HIV Research and Treatment
  • Cytomegalovirus and herpesvirus research
  • Immunodeficiency and Autoimmune Disorders
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Polyomavirus and related diseases
  • vaccines and immunoinformatics approaches
  • Animal Virus Infections Studies
  • Diabetes and associated disorders
  • Full-Duplex Wireless Communications
  • Hematopoietic Stem Cell Transplantation
  • Consumer Attitudes and Food Labeling
  • Cell Adhesion Molecules Research
  • SARS-CoV-2 detection and testing
  • Viral Infections and Immunology Research
  • Systemic Sclerosis and Related Diseases
  • Antioxidant Activity and Oxidative Stress

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
2015-2025

University of Brescia
1991-2023

University of Padua
2021

National Institutes of Health
2021

Istituto Superiore di Sanità
2010

LivaNova (Italy)
1999

Consorzio Interuniversitario per le Biotecnologie
1990-1997

National Research Council
1992-1993

Istituto di Tipizzazione Tissutale e Problemi della Dialisi
1990

T cells are involved in the early identification and clearance of viral infections also support development antibodies by B cells. This central role for makes them a desirable target assessing immune response to SARS-CoV-2 infection. Here, we combined two high-throughput profiling methods create quantitative picture T-cell SARS-CoV-2. First, at individual level, deeply characterized 3 acutely infected 58 recovered COVID-19 subjects experimentally mapping their CD8 through antigen stimulation...

10.1101/2020.07.31.20165647 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-08-04

10.1038/s41591-022-01724-3 article EN Nature Medicine 2022-02-17

Immune system aging is becoming a field of increasing public health interest because prolonged life expectancy, which not paralleled by an increase in expectancy. As age progresses, innate and adaptive immune systems undergo changes, are defined, respectively, as inflammaging senescence. A wealth available data demonstrates that these two conditions closely linked, leading to greater vulnerability elderly subjects viral, bacterial, opportunistic infections well lower post-vaccination...

10.3390/microorganisms12040775 article EN cc-by Microorganisms 2024-04-11

Abstract Synovial fluids of patients with rheumatoid arthritis contain activated T lymphocytes that may play an important role in the pathogenesis disease. Previous studies have suggested cell receptor (TcR) repertoire these cells is restricted, reflecting vivo selection a limited number specificities at site inflammation. To characterize better populations we used polymerase chain reaction technology to estimate proportion TcR α and β RNA containing any particular V elements from...

10.1002/eji.1830210231 article EN European Journal of Immunology 1991-02-01
Paul Bastard Sara E. Vazquez Jamin Liu Matthew T. Laurie Chung‐Yu Wang and 95 more Adrian Gervais Tom Le Voyer Lucy Bizien Colin R. Zamecnik Quentin Philippot Jérémie Rosain Émilie Catherinot Andrew Willmore Anthea Mitchell Rebecca Bair Pierre Garçon Heather Kenney Arnaud Fekkar Maria Salagianni Garyphallia Poulakou Eleni Siouti Sabina Sahanic Ivan Tancevski Günter Weiß Laurenz Nagl Jérémy Manry Sotiriјa Duvlis Daniel Arroyo‐Sánchez Estela Paz‐Artal Luis Rubio Cristiano Perani Michela Bezzi Alessandra Sottini Virginia Quaresima Lucie Roussel Donald C. Vinh Luis Felipe Reyes Margaux Garzaro Nevin Hatipoğlu David Boutboul Yacine Tandjaoui-Lambiotte A. Borghesi Anna Aliberti Irene Cassaniti Fabienne Venet Guillaume Monneret Rabih Halwani Narjes Saheb Sharif‐Askari Jeffrey J. Danielson Sonia Burrel Caroline Morbieu Yuriy Stepanovskyy Анастасія Бондаренко Алла Волоха Oksana Boyarchuk Alenka Gagro Mathilde Neuville Bénédicte Neven Sevgi Keleş Romain Hernu Antonin Bal Antonio Novelli Giuseppe Novelli Kahina Saker Oana Ailioaie Arnau Antolí Éric Jeziorski Gemma Rocamora-Blanch Carla Teixeira Clarisse Delaunay Marine Lhuillier Paul Le Turnier Yu Zhang Matthieu Mahévas Qiang Pan‐Hammarström Hassan Abolhassani Thierry Bompoil Karim Dorgham Guy Gorochov Cédric Laouénan Carlos Rodríguez‐Gallego Lisa F. P. Ng Laurent Rénia Aurora Pujol Alexandre Bélot F. Raffi Luís M. Allende Javier Martínez‐Picado Tayfun Özçelık Luisa Imberti Luigi D. Notarangelo Jesús Troya Xavier Solanich Shen‐Ying Zhang Anne Puel Michael R. Wilson Sophie Trouillet‐Assant Laurent Abel Emmanuelle Jouanguy Chun Ye

Life-threatening “breakthrough” cases of critical COVID-19 are attributed to poor or waning antibody (Ab) response SARS-CoV-2 vaccines in individuals already at risk. Preexisting auto-Abs neutralizing type I IFNs underlie least 15% pneumonia unvaccinated individuals; their contribution hypoxemic breakthrough vaccinated people is unknown. We studied a cohort 48 (aged 20 86 years) who received two doses messenger RNA (mRNA) vaccine and developed infection with 2 weeks 4 months later. Ab levels...

10.1126/sciimmunol.abp8966 article EN cc-by Science Immunology 2022-06-14

SEN virus (SEN-V) is a recently identified single-stranded, circular DNA virus. Two SEN-V variants (SENV-D and SENV-H) were assayed by polymerase chain reaction (PCR) to investigate their role in the causation of transfusion-associated non-A E hepatitis. The incidence infection after transfusion was 30% (86 286) compared with 3% (3 97) among nontransfused controls (P < .001). Transfusion risk increased number units transfused .0001) donor-recipient linkage for shown sequence homology....

10.1053/jhep.2001.24268 article EN Hepatology 2001-05-01

Abstract The ability of patients with hematologic malignancies (HM) to develop an effective humoral immune response after COVID-19 is unknown. A prospective study was performed monitor the SARS-CoV-2 follicular lymphoma (FL), diffuse large B-cell (DLBCL), chronic lymphoproliferative disorders (CLD), multiple myeloma (MM), or myelodysplastic/myeloproliferative syndromes (MDS/MPN). Antibody (Ab) levels nucleocapsid (N) and spike (S) protein were measured at +1, +3, +6 months nasal swabs became...

10.1038/s41408-021-00546-9 article EN cc-by Blood Cancer Journal 2021-09-14

Dysregulation in neutrophil extracellular trap (NET) formation and degradation may play a role the pathogenesis severity of COVID-19; however, its pediatric manifestations this disease, including multisystem inflammatory syndrome children (MIS-C) chilblain-like lesions (CLLs), otherwise known as "COVID toes," remains unclear. Studying multinational cohorts, we found that, CLLs, NETs were significantly increased serum skin. There was geographic variability prevalence MIS-C, association with...

10.1172/jci.insight.160332 article EN cc-by JCI Insight 2022-07-19

The lack of adenosine deaminase (ADA) leads to the accumulation toxic metabolites, resulting in SCID. If disease is left untreated, it likely have a fatal outcome early infancy. Because hematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy with pegylated bovine ADA (PEG-ADA) are both provided our hospital, we undertook retrospective longitudinal comparative study extent lymphocyte recovery two groups treated ADA-SCID children. Together classical immunological...

10.4049/jimmunol.1001770 article EN The Journal of Immunology 2010-11-06

Combination of chemotherapy and immunotherapy to increase the effectiveness an antitumor immune response is currently regarded as attractive strategy. In a pilot clinical trial, we have recently documented melanoma antigen A (Melan-A)-specific, tumor-reactive, long-lasting effector-memory CD8(+) T cells after administration dacarbazine (DTIC) 1 day before peptide vaccination in patients. Global transcriptional analysis revealed DTIC-induced activation genes involved leukocyte activation. To...

10.1158/0008-5472.can-10-1326 article EN Cancer Research 2010-09-08

A 31-year-old woman affected by multiple sclerosis (MS) experienced generalized tonic–clonic seizures 2 months after the second alemtuzumab cycle. Positive JC virus (JCV)-DNA in cerebrospinal fluid (CSF) and lesion iconography at magnetic resonance imaging (MRI) were suggestive of progressive multifocal leukoencephalopathy (PML). After 1 month, during full-blown immune reconstitution inflammatory syndrome, JCV-DNA became negative symptoms gradually improved. New T- B-cell output diversity...

10.1177/1352458519832259 article EN Multiple Sclerosis Journal 2019-04-09

Background: Fingolimod inhibits lymphocyte egress from lymphoid tissues, thus altering the composition of peripheral pool multiple sclerosis patients. Objective: The objective this paper is to evaluate whether fingolimod determines a decrease newly produced T- and B-lymphocytes in blood reduction T-cell receptor repertoire diversity that may affect immune surveillance. Methods: Blood samples were obtained patients before therapy initiation then after six 12 months. Newly T B lymphocytes...

10.1177/1352458514551456 article EN Multiple Sclerosis Journal 2014-11-12

Abstract Background Assessment of T-cell diversity, besides giving insights about the molecular basis tumor antigen recognition, has clinical implications since it provides criteria for evaluating antigen-specific T cells clinically relevant spontaneous and vaccine-induced anti-tumor activity. Melan-A is one melanoma antigens most frequently recognized by peripheral tumor-infiltrating lymphocytes in HLA-A2+ patients. Many trials involving vaccination have been conducted using modified...

10.1186/1479-5876-7-21 article EN cc-by Journal of Translational Medicine 2009-03-24

Abstract Background Coronavirus disease 2019 (COVID-19) severity seems to be influenced by genetic background, sex, age, and presence of specific comorbidities. So far, little attention has been paid sex-specific variations demographic, clinical, laboratory features COVID-19 patients referred the same hospital in two consecutive pandemic waves. Methods Demographic, data were collected 1000 (367 females 633 males), 500 hospitalized first wave second one, at ASST Spedali Civili Brescia from...

10.1186/s13293-021-00386-z article EN cc-by Biology of Sex Differences 2021-08-11

Progressive multifocal leukoencephalopathy (PML) usually occurs in patients with severe immunosuppression, hematological malignancies, chronic inflammatory conditions or receiving organ transplant. Recently, PML has also been observed treated monoclonal antibodies. By taking advantage of the availability samples from a multiple sclerosis (MS) patient natalizumab, antibody anti-α4 integrin, who developed and was monitored starting before therapy initiation, we investigated fate T B...

10.1371/journal.pone.0034493 article EN cc-by PLoS ONE 2012-04-04

Abstract Background The immune system reconstitution in HIV-1- infected patients undergoing combined antiretroviral therapy is routinely evaluated by T-cell phenotyping, even though the infection also impairs B-cell mediated immunity. To find new laboratory markers of effectiveness, both B- and T- recovery were means a follow-up study long-term treated patients, with special focus on measure T-lymphocyte production. Methods A longitudinal analysis was performed samples obtained from...

10.1186/1479-5876-10-94 article EN cc-by Journal of Translational Medicine 2012-05-16

To document the prevalence and routes of transmission SEN virus (SEN-V) in community-based individuals patients referred to a liver disease unit, stored serum samples obtained from 160 Canadian Inuit 140 with were tested for SEN-V DNA by polymerase chain reaction. In population, was present 57 (36%) persons. SEN-V-positive tended be younger more often male. Liver enzyme levels serologic markers hepatitis A B viruses similar SEN-V-negative individuals. 30 (21%) disease. Age, sex, risk factors...

10.1086/342329 article EN Clinical Infectious Diseases 2002-09-25
Coming Soon ...